Teva CEO Says Generics to Keep Growing and Remain Profitable
Teva CEO Francis said generics would continue to grow and be profitable, citing the biosimilars pipeline despite growth in branded drugs.
Teva CEO Francis said generics would continue to grow and be profitable, citing the biosimilars pipeline despite growth in branded drugs.